2022
DOI: 10.1038/s41541-022-00484-y
|View full text |Cite
|
Sign up to set email alerts
|

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control

Abstract: Adjuvants play a determinant role in cancer vaccination by optimally activating APCs and shaping the T cell response. Bacterial-derived lipid A is one of the most potent immune-stimulators known, and is recognized via Toll-like receptor 4 (TLR4). In this study, we explore the use of the synthetic, non-toxic, lipid A analog CRX-527 as an adjuvant for peptide cancer vaccines. This well-defined adjuvant was covalently conjugated to antigenic peptides as a strategy to improve vaccine efficacy. We show that couplin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 50 publications
0
1
0
Order By: Relevance
“…The inclusion of the ASO4 adjuvant in this vaccine has been shown to evoke a more robust immune response in vaccinated people (98). Other synthetic lipid adjuvants such as 3M-052, GLA-SE, CRX-527, Ono-4007, OM-174, and DT-5461 have also been developed and applied for this purpose (99)(100)(101)(102)(103). Despite their somewhat limited clinical efficacy on their own, incorporating lipids as adjuvants in cancer therapy has promising potential, especially for tumors of low immunogenicity.…”
Section: Lipids As Adjuvantsmentioning
confidence: 99%
“…The inclusion of the ASO4 adjuvant in this vaccine has been shown to evoke a more robust immune response in vaccinated people (98). Other synthetic lipid adjuvants such as 3M-052, GLA-SE, CRX-527, Ono-4007, OM-174, and DT-5461 have also been developed and applied for this purpose (99)(100)(101)(102)(103). Despite their somewhat limited clinical efficacy on their own, incorporating lipids as adjuvants in cancer therapy has promising potential, especially for tumors of low immunogenicity.…”
Section: Lipids As Adjuvantsmentioning
confidence: 99%
“…In this context, GP5-derived peptides have been studied as neutralization epitopes, particularly linear peptides [ 32 ]. Peptides can bind to MHC and activate the immune system [ 33 ]; they are also capable of activating dendritic cells (DCs), promoting DC maturation and T-cell activation in vitro, stimulating DC migration, and the priming of functional T-cells in vivo [ 34 ].…”
Section: Introductionmentioning
confidence: 99%